SE412587B - Forfarande for framstellning av substituerade imidazoler - Google Patents
Forfarande for framstellning av substituerade imidazolerInfo
- Publication number
- SE412587B SE412587B SE7414512A SE7414512A SE412587B SE 412587 B SE412587 B SE 412587B SE 7414512 A SE7414512 A SE 7414512A SE 7414512 A SE7414512 A SE 7414512A SE 412587 B SE412587 B SE 412587B
- Authority
- SE
- Sweden
- Prior art keywords
- imidazols
- procedure
- preparing substituted
- substituted
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42155373A | 1973-12-04 | 1973-12-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7414512L SE7414512L (de) | 1975-06-05 |
| SE412587B true SE412587B (sv) | 1980-03-10 |
Family
ID=23671021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7414512A SE412587B (sv) | 1973-12-04 | 1974-11-19 | Forfarande for framstellning av substituerade imidazoler |
Country Status (10)
| Country | Link |
|---|---|
| AU (1) | AU7575074A (de) |
| BE (1) | BE822881A (de) |
| CH (1) | CH609976A5 (de) |
| DE (1) | DE2457127A1 (de) |
| DK (1) | DK138947B (de) |
| FR (1) | FR2253517B1 (de) |
| GB (1) | GB1451029A (de) |
| HU (1) | HU168824B (de) |
| NL (1) | NL7415142A (de) |
| SE (1) | SE412587B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8405588D0 (sv) * | 1984-11-08 | 1984-11-08 | Haessle Ab | New compounds |
| JPH0441481A (ja) * | 1990-06-05 | 1992-02-12 | Nippon Synthetic Chem Ind Co Ltd:The | イミダゾール類のハロゲン化方法 |
| WO1999024038A1 (en) | 1997-11-07 | 1999-05-20 | Johns Hopkins University | Methods for treatment of disorders of cardiac contractility |
| DE60137635D1 (de) | 2000-06-28 | 2009-03-26 | Merck & Co Inc | Verwendung von allopurinol zur behandlung von bluthochdruck |
-
1974
- 1974-11-19 SE SE7414512A patent/SE412587B/xx unknown
- 1974-11-20 NL NL7415142A patent/NL7415142A/xx not_active Application Discontinuation
- 1974-11-20 DK DK601974AA patent/DK138947B/da unknown
- 1974-11-26 AU AU75750/74A patent/AU7575074A/en not_active Expired
- 1974-11-28 GB GB5158274A patent/GB1451029A/en not_active Expired
- 1974-11-29 CH CH1587974A patent/CH609976A5/xx not_active IP Right Cessation
- 1974-12-02 FR FR7439359A patent/FR2253517B1/fr not_active Expired
- 1974-12-03 BE BE151094A patent/BE822881A/xx unknown
- 1974-12-03 HU HUME1806A patent/HU168824B/hu unknown
- 1974-12-03 DE DE19742457127 patent/DE2457127A1/de not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| BE822881A (fr) | 1975-06-03 |
| NL7415142A (nl) | 1975-06-06 |
| SE7414512L (de) | 1975-06-05 |
| FR2253517A1 (de) | 1975-07-04 |
| FR2253517B1 (de) | 1978-03-24 |
| AU7575074A (de) | 1976-05-27 |
| HU168824B (de) | 1976-07-28 |
| CH609976A5 (en) | 1979-03-30 |
| GB1451029A (en) | 1976-09-29 |
| DK138947C (de) | 1979-05-07 |
| DK601974A (de) | 1975-07-28 |
| DE2457127A1 (de) | 1975-06-05 |
| DK138947B (da) | 1978-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE419981B (sv) | Forfarande for framstellning av 1alfa-hydroxi-vitamin d-derivat | |
| SE416299B (sv) | Forfarande for framstellning av heterocykliska foreningar | |
| SE453667B (sv) | Forfarande for framstellning av polyeterimider | |
| SE418190B (sv) | Forfarande for framstellning av hydrauliska organopolysiloxanelaster | |
| SE423631B (sv) | Forfarande for framstellning av oxaalhyl-dialkylxantiner | |
| NO138585C (no) | Fremgangsmaate for fremstilling av for for kjaeledyr | |
| SE435713B (sv) | Forfarande for framstellning av 1,3-bensoxazoler | |
| RO68025A (ro) | Procedeu pentru obtinerea 3-metilmercaptopropionaldehidei | |
| SE420720B (sv) | Forfarande for framstellning av 2,6-disubstuerade fenylaminoguanidinforeningar | |
| SE411212B (sv) | Forfarande for framstellning av 3-halogen-cefalosporiner | |
| SE420098B (sv) | Forfarande for framstellning av linkomycinderivat | |
| NO146596C (no) | Fremgangsmaate for fremstilling av 6-deoksytetracykliner | |
| NO790627L (no) | Fremgangsmaate for fremstilling av hydroksyalkylxantiner | |
| SE417601B (sv) | Forfarande for framstellning av amidinokarbamider | |
| NO151585C (no) | Fremgangsmaate for fremstilling 6-deoksyoksytetracyklin | |
| SE405700B (sv) | Forfarande for forvermning av former | |
| SE413316B (sv) | Forfarande for framstellning av 7beta-amino-7alfa-metoxicefalosporinestrar | |
| SE421313B (sv) | Forfarande for framstellning av 2-(fenoxialkyltio)-5-nitroimidazoler | |
| SE421129B (sv) | Forfarande for framstellning av poly-n-alkyl-iminoalaner | |
| SE418176B (sv) | Forfarande for framstellning av substituerade indanettiksyror | |
| SE419543B (sv) | Forfarande for framstellning av vissa angivna isokinolinderivat | |
| FI55498C (fi) | Foerfarande foer framstaellning av hypoglycemiska pyridinkarboxamid-sulfonylureafoereningar | |
| SE410156B (sv) | Forfarande for framstellning av lodmaterial | |
| SE409994B (sv) | Forfarande for framstellning av amidinokarbamider | |
| SE411211B (sv) | Forfarande for framstellning av 3-halogencefalosporiner |